The full content will be available shortly. Thank you for your patience!
New bio signals in sleep studies scoring
New bio signals in sleep studies scoring
Gonzalo Labarca 1, 2, Mario Henríquez-Beltrán 3, 4, 5, Daniel Solomon 1
1 Department of Respiratory Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; 2 Division of Respiratory, Allergy and Sleep Medicine, Mayo Clinic, Jacksonville, USA; 3 Translational Research in Respiratory Medicine, Hospital Universitari Arnau de Vilanova-Santa Maria, Lleida Institute for Biomedical Research Dr. Pifarré Foundation (IRBLleida), Lleida, Spain; 4 CIBER of Respiratory diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain; 5 Núcleo de Investigación en Ciencias de la Salud, Universidad Adventista de Chile, Chillán, Chile
*Correspondence: Gonzalo Labarca. Email: glabarcat@gmail.com
Abstract
Obstructive sleep apnea is conventionally diagnosed using the apnea-hypopnea index (AHI), which measures only the frequency of respiratory events. However, AHI ignores key event features and effects, such as hypoxemia patterns, ventilatory drops, and autonomic responses, hindering accurate evaluation of CPAP benefits and cardiovascular risk prediction. New metrics from polysomnography (PSG) secondary analysis provide valuable complementary data. This review focuses on four: Hypoxic burden (HB), ventilatory burden (VB), delta heart rate (ΔHR), and pulse arrival time (PAT). High HB correlates with increased cardiovascular events, cardiovascular mortality, and all-cause mortality in diverse studies. ΔHR, indicating heart rate changes during events, links to subclinical cardiovascular disease, mortality, and possible CPAP interactions. VB, from airflow and effort, predicts new cardiovascular disease. PAT, reflecting blood pressure changes, associates with subclinical pathology. Combining these with AHI could improve risk assessment and treatment decisions.
Keywords: Sleep apnea. Obstructive. Hypoxemia. Heart rate response. Mortality.
